Skip to search formSkip to main contentSkip to account menu

HU 211

Known as: 6H-Dibenzo(b,d)pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aS-trans)-, HU-211 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Recently, a new Law, named the "derivative law" (first addition, schedule drug change--2010), was accepted in the Israeli… 
2008
2008
We hypothesized that dexanabinol can prevent neuronal death by protecting neuronal lysosomes from nitric oxide (NO)-mediated… 
Review
2004
Review
2004
SUMMARY This study reviews human clinical experience to date with several synthetic cannabinoids, including nabilone… 
Review
2000
Review
2000
Unlike natural cannabinoids which belong to the 6aR - trans series, the synthetic dexanabinol (HU-211), a 6aS-trans enantiomer… 
1999
1999
ABSTRACT: Neuroprotective effects of HU‐211 (dexanabinol), a synthetic nonpsychotropic analog of tetrahydrocannabinol, on brain… 
Highly Cited
1996
Highly Cited
1996
HU-211 is a novel synthetic analog of tetrahydrocannabinol that was recently shown in animal models to be nonpsychotropic. In… 
1996
1996
The negative and positive enantiomers of 7‐hydroxy‐ Δ6‐tetrahydrocannabinol‐dimethylheptyl (designated HU‐210 and HU‐211… 
1994
1994
The novel tricyclic-terpenoid type cannabinoid, HU-211, was tested in gerbils and rats for protection against the effects of…